Skip to main content
Molecular Therapy Oncolytics logoLink to Molecular Therapy Oncolytics
. 2021 Nov 29;23:531–533. doi: 10.1016/j.omto.2021.11.015

lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC

Bohao Zheng, Jiwen Wang, Kun Fan, Wentao Sun, Wenze Wan, Zhihui Gao, Xiaojian Ni, Dexiang Zhang, Xiaoling Ni, Tao Suo, Han Liu , Houbao Liu ∗∗, Sheng Shen ∗∗∗
PMCID: PMC8640164  PMID: 34901394

Main text

Molecular Therapy: Oncolytics 23, 124–137; December 2021

In the originally published version of this article, there were some similar transwell pictures between Figures 3 and 6. In order to correct this mistake, the authors carefully reviewed the experiment result, and the transwell figures for NOZ in Figure 6, including migration and invasion assay, have been changed in the latest version of Figure 6. This change does not influence the conclusion but could make it more reliable and convincing. The authors regret this error.

graphic file with name gr6o.jpg

Figure 6. The rescue assay confirmed that lncRNA RP11-147L13.8 performs its biological function through suppressing the c-Jun-ser73 phosphorylation in GBC cell lines (original)

graphic file with name gr6c.jpg

Figure 6. The rescue assay confirmed that lncRNA RP11-147L13.8 performs its biological function through suppressing the c-Jun-ser73 phosphorylation in GBC cell lines (corrected)

Contributor Information

Han Liu, Email: liu.han@zs-hospital.sh.cn.

Houbao Liu, Email: liu.houbao@zs-hospital.sh.cn.

Sheng Shen, Email: shen.sheng@zs-hospital.sh.cn.


Articles from Molecular Therapy Oncolytics are provided here courtesy of American Society of Gene & Cell Therapy

RESOURCES